A study of CD10 positivity of stromal cells in core needle biopsy specimen of breast cancer patients and its relation with histological grade and lymphovascular invasion

被引:2
|
作者
Boler, Anup K. [1 ]
Akhtar, Sana [2 ]
Bandyopadhyay, Arghya [1 ]
Bandyopadhyay, Goutam [1 ]
机构
[1] Burdwan Med Coll & Hosp, Dept Pathol, Burdwan, W Bengal, India
[2] Murshidabad Med Coll & Hosp, Dept Pathol, Blood Bank, Berhampur, Odisha, India
关键词
CD10; positivity; histopathological grading; invasive breast carcinoma; PROGNOSTIC-FACTOR; CARCINOMA; EXPRESSION;
D O I
10.4103/IJPM.IJPM_601_20
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background: In core needle biopsy (CNB) often the histological grade of invasive breast carcinoma is under-estimated due to heterogeneity of epithelial component. Stroma is relatively homogenous throughout the tumor and strong CD10 stromal positivity is proposed to be associated with high tumor grade. Aims and Objectives: The aim of this work was to study the expression of CD10 in stromal cells of invasive carcinoma of breast, no specific type (NST) in CNB specimens, and analyze its association with final histological grade and lymphovascular invasion (LVI). Materials and Methods: A total of 50 cases of invasive carcinoma of breast, NST were studied for 18 months. CNB specimens were graded according to modified Scarff-Bloom-Richardson (SBR) system and CD10 positivity was assessed in stromal cells. Mastectomy specimens were also similarly graded. Relation of stromal CD10 positivity with histological grading and LVI was studied. Statistics: Associations between the variables were studied by Chi-square test. A value of P < 0.05 was considered to be statistically significant. Results: On CNB 46% patients had a grade 2 tumor, followed by 30% grade 3 and 24% grade 1 tumor. Strong CD10 positivity was seen in 40% cases, 32% showed weak positivity and 28% were negative for CD10 in stromal cells in CNB specimen. On evaluation of mastectomy specimen 48% of the patients had a grade 2 tumor, followed by 40% grade 3 tumor and 12% grade 1 tumor. Strong CD10 positivity was found to be significantly associated with final grade 3 tumor (P< 0.001) and LVI (P= 0.005). Conclusions: There was underestimation of histological grade on CNB, while strong stromal CD10 positivity in CNB was significantly associated with final grade 3 tumor and LVI.
引用
收藏
页码:460 / 463
页数:4
相关论文
共 8 条
  • [1] Impact of prognoses on the discrepancies in histological grade of breast cancer between core needle biopsy and surgical excision specimen
    Nakamura, Rikiya
    Yamamoto, Naohito
    Miyaki, Toshiko
    Teranaka, Ryoutarou
    Itami, Makiko
    CANCER RESEARCH, 2018, 78 (04)
  • [2] Meta-analysis of the concordance of histological grade of breast cancer between core needle biopsy and surgical excision specimen
    Knuttel, F. M.
    Menezes, G. L. G.
    van Diest, P. J.
    Witkamp, A. J.
    van den Bosch, M. A. A. J.
    Verkooijen, H. M.
    BRITISH JOURNAL OF SURGERY, 2016, 103 (06) : 644 - 655
  • [3] CD10 expression in stromal cells of patients with breast cancer: a poor prognostic marker
    Bacha, Dhouha
    Ben Amor, Anissa
    Ben Farhat, Farah
    Ben Slama, Sana
    Lahmar, Ahlem
    Bouraoui, Saadia
    Triki, Amel
    PAN AFRICAN MEDICAL JOURNAL, 2020, 37 : 1 - 14
  • [4] A study of the accuracy of core needle biopsy in determining histological grade and receptor status in invasive breast cancer
    Gupta, S. K.
    Pandey, R.
    Kumar, M.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S82 - S83
  • [5] Reliability of histological malignancy grade, ER and HER2 status on core needle biopsy vs surgical specimen in breast cancer
    Munch-Petersen, Helga D.
    Rasmussen, Birgitte B.
    Balslev, Eva
    APMIS, 2014, 122 (09) : 750 - 754
  • [6] The reliability of histological grade in breast cancer core needle biopsies depends on biopsy size: a comparative study with subsequent surgical excisions
    Focke, Cornelia M.
    Decker, Thomas
    van Diest, Paul J.
    HISTOPATHOLOGY, 2016, 69 (06) : 1047 - 1054
  • [7] Histological malignancy grade, estrogen receptor and HER2 receptor status on core needle biopsy compared to surgical specimen in breast cancer - how accurate is it?
    Munch-Petersen, H. D.
    Balslev, E.
    APMIS, 2013, 121 : 8 - 8
  • [8] Breast Cancer Cells are in Biopsy Channel in Postoperative Material from Mastectomies Preformed 3days after Core Needle Biopsy (CNB) but They Do Not Persist at Biopsy Channel Apart from the Tumor after 10 Days from the CNB Procedurea Study of seven Cases
    Lewitowicz, Piotr
    Wincewicz, Andrzej
    Horecka-Lewitowicz, Agata
    Matykiewicz, Jaroslaw
    Koziel, Dorota
    Gluszek, Stanislaw
    Koda, Mariusz
    Sulkowski, Stanislaw
    BREAST JOURNAL, 2015, 21 (05): : 558 - 561